---
figid: PMC9553391__OMCL2022-8965903.003
pmcid: PMC9553391
image_filename: OMCL2022-8965903.003.jpg
figure_link: /pmc/articles/PMC9553391/figure/fig3/
number: Figure 3
figure_title: ''
caption: Anlo boosted tumor-infiltrating NK cells. (a) MC38/CT26 cells were injected
  subcutaneously into mice, and after a week, mice were treated with PBS or anlo for
  a week (n = 6). (b) Gross appearance, tumor volume, and tumor weight of MC38 tumor.
  (c) Gross appearance, tumor volume, and tumor weight of CT26 tumor. (d) Flow cytometric
  analysis of MC38/CT26 tumor-infiltrating NK cells.
article_title: Anlotinib Benefits the Î±PDL1 Immunotherapy by Activating ROS/JNK/AP-1
  Pathway to Upregulate PDL1 Expression in Colorectal Cancer.
citation: Bixian Luo, et al. Oxid Med Cell Longev. 2022;2022:8965903.
year: '2022'

doi: 10.1155/2022/8965903
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
